The $8 billion award handed to a man who developed excessive breast tissue after using the antipsychotic drug Risperdal is likely the largest verdict in Pennsylvania history, according to a review of The Legal’s archives. But, court watchers agree, it is unlikely to remain that size for long.

On Tuesday, a Philadelphia jury ruled 10-2 to slam Johnson & Johnson and its subsidiary Janssen Pharmaceuticals with the multibillion-dollar verdict. The award was solely for punitive damages after the case, Murray v. Janssen, initially came to a $1.75 million verdict by a separate jury, which was later reduced to $680,000.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]